: Sunzen Biotech Bhd hopes to achieve record earnings for this financial year , underpinned by strong demand in its loan financing and traditional Chinese medicine segments, said group managing director and CEO Teo Yek Ming.Teo said the group will focus on these two segments, concentrating on its health and wellness subsidiary Ecolite and financing arm Finsource Credit respectively.
Its loan financing segment, which is a new business venture acquired last year, recorded RM1.09 million in profit for the period of seven months up to Dec 31, 2021 and RM1.75 million in revenue. He added that if the Health Ministry chooses to implement a ban on the use of animal antibiotics, it will be a good opportunity for the group to showcase and profit from its product.